European court rules on borderline products
The Court of Justice of the European Union (CJEU) has given judgment in case C-109/12, which concerns some practical effects of the borderline between medicinal products and medical devices and arises from a reference from the Finnish Courts.
The case concerns a capsule used for correcting bacterial imbalances in the vagina. The product was marketed in Finland and continues to be marketed in other member states as a medical device with a CE mark. The Finnish National Agency for Medicines decided in 2008 that the capsule should no longer be considered to be a medical device but was instead a medicinal product that required a marketing authorisation. At the time, a similar product had recently been classified in Finland as a medicinal product. The manufacturer challenged this decision in the Finnish courts and the Finnish Supreme Administrative Court referred three questions to the CJEU for a preliminary ruling.
The significance of whether a product should be considered to be a medical device or a medicinal product is apparent in the approval process that must be gone through before marketing. A medicinal product may not be marketed without a marketing authorisation, which requires clinical data supporting the safety and efficacy of the product. Less onerous obligations currently apply to medical devices. Furthermore, there are provisions of the legislation governing medical devices that provide that a product that has been CE marked when it is not actually a medical device may have to be removed from circulation…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
For the tax year from 6 April 2014, the standard lifetime allowance has reduced from £1.5m to £1.25m.
One of the areas highlighted last year by the Regulator was the regulation of workplace DC pension schemes.
Analysis from The Lawyer
As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014.
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world